Author: Healio ophthalmology

ACP offers recommendations to CMS’s 2018 Physician Fee Schedule proposal

by  •  • 0 Comments

In a letter to CMS, the American College of Physicians offered several recommendations on its proposed rule for the 2018 Medicare Physician Fee Schedule, focusing on further aligning various Medicare reporting programs and reducing administrative burdens for clinicians.“As a practicing primary care internist, I am greatly encouraged that CMS is proposing substantial improvements to help me and my colleagues provide coordinated, patient-centered, high value and team-based care to our patients,” Jacqueline W. Fincher, MD, MACP, chair of the Medical Practice and Quality Committee for the American College of Physicians (ACP), (Read more...)

pSivida reports $18.5 million yearly loss

by  •  • 0 Comments

In the fourth fiscal quarter of 2017, pSivida reported a net loss of $6.1 million, or $0.16 per share, compared with a net loss of $6.4 million, or $0.19 per share, in 2016’s fourth quarter. Revenue for the quarter was reported at $701,000 compared with $304,000 in the fourth quarter of 2016, according to a press release.

Read more →

PUBLICATION EXCLUSIVE: Heads or tails: Will headwinds or tailwinds prevail for private equity firms buying ophthalmic practices?

by  •  • 0 Comments

“Physicians Resource Group Inc. is the nation’s leading provider of physician practice management services to ophthalmic and optometric practices. PRG develops integrated eye care delivery systems through affiliations with locally prominent physician practices in strategic geographic areas across the United States. PRG acquires the operating assets of these practices and develops the practices into eye care networks by providing management expertise, marketing, information systems, capital resources and ancillary services such as surgery centers and optical shops.— 1995: PR Newswire“Throughout the country, solo practitioners and group practices are looking for partners (Read more...)

PUBLICATION EXCLUSIVE: Around the world in 5 days: My personal premium surgeon story

by  •  • 0 Comments

My story begins when I finally could truly understand the account of my father’s visual handicap. When my father was age 8 and living outside Glasgow, Scotland, a local epidemic of bacterial meningitis about 78 years ago took the lives of eight of his best childhood friends, and caused complete deafness in one friend and complete blindness in one eye and partial visual loss in the other eye of my father. He remarkably lived on to survive colon cancer twice and prostate cancer once, and fight Parkinson’s disease for 40 (Read more...)

PUBLICATION EXCLUSIVE: IRIS Registry offers many benefits for US ophthalmologists

by  •  • 0 Comments

Big data is defined as extremely large data sets that may be analyzed computationally to reveal patterns, trends and associations, especially relating to human behavior and interactions. An extraordinary amount of human and financial capital is being invested toward collecting and analyzing big data. Potential contributions to medicine include enhancing the diagnosis and management of disease; targeting personalized medicine, in which patient profiles can be utilized to select ideal treatments, which today is especially useful in oncology; improving practice management; determining group and individual buying patterns to enhance marketing; and (Read more...)

Johnson & Johnson Vision completes TearScience acquisition

by  •  • 0 Comments

Johnson & Johnson Vision’s acquisition of TearScience has been completed, according to a company press release.The company announced in August that it would acquire TearScience, which has FDA clearance for products to evaluate meibomian gland health and treat meibomian gland dysfunction, the leading cause of dry eye disease. Financial terms of the deal were not disclosed.

Read more →